Martin Austin
Chief Executive Officer at TransformRX GmbH
Profile
Martin Austin is currently the Chairman at Zestagen AG, Director at AlgiPharma APR AS, RSA AG, and Devirex AG, Managing Director & Owner at TransformRX GmbH, and Partner at Ventac Partners GmbH.
He is also a Partner at MarraM Advisors SARL.
In the past, he served as Chairman & Director-Business Development at Guard Therapeutics International AB from 2016 to 2018, Chairman at Preelumina Diagnostics AB, Head-Business Development at Hoffmann-La Roche, Inc., and Principal at Paul Capital Partners LP.
Martin Austin active positions
| Companies | Position | Start |
|---|---|---|
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 01/09/2010 |
| Zestagen AG | Chairman | - |
| RSA AG | Director/Board Member | - |
| Devirex AG | Director/Board Member | - |
MarraM Advisors SARL
 MarraM Advisors SARL Investment ManagersFinance MarraM Advisors SARL provides investment advisory services. | Corporate Officer/Principal | - |
| TransformRX GmbH | Chief Executive Officer | - |
| AlgiPharma APR AS | Director/Board Member | - |
Former positions of Martin Austin
| Companies | Position | End |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Chairman | 26/11/2018 |
| Preelumina Diagnostics AB | Chairman | - |
| ░░░░ ░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| Private companies | 10 |
|---|---|
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Finance |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Commercial Services |
| AlgiPharma APR AS | |
| Preelumina Diagnostics AB | |
| Zestagen AG | |
| Devirex AG | |
MarraM Advisors SARL
MarraM Advisors SARL Investment ManagersFinance MarraM Advisors SARL provides investment advisory services. | Finance |
| TransformRX GmbH | |
| RSA AG |
- Stock Market
- Insiders
- Martin Austin
